Gene · 9682
Papers1,858
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 1,858
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of a cuproptosis and copper metabolism gene-related lncRNAs prognostic signature associated with clinical and immunological characteristics of hepatocellular carcinoma. | Front Oncol | 2023 | 37056336 | PubTator, text mining | PubMed |
| Aid or Antagonize: Nuclear Long Noncoding RNAs Regulate Host Responses and Outcomes of Viral Infections. | Cells | 2023 | 37048060 | PubTator, text mining | PubMed |
| Multi-ancestry meta-analysis of tobacco use disorder prioritizes novel candidate risk genes and reveals associations with numerous health outcomes. | medRxiv | 2023 | 37034728 | PubTator, text mining | PubMed |
| Ferroptosis: Mechanism and potential applications in cervical cancer. | Front Mol Biosci | 2023 | 37025659 | PubTator, text mining | PubMed |
| Histone methyltransferase SETD2: An epigenetic driver in clear cell renal cell carcinoma. | Front Oncol | 2023 | 37025591 | PubTator, text mining | PubMed |
| Effects of prenatal pesticide exposure on the fetal brain and placenta transcriptomes in a rodent model. | Toxicology | 2023 | 37019170 | PubTator, text mining | PubMed |
| Integrative network-based analysis on multiple Gene Expression Omnibus datasets identifies novel immune molecular markers implicated in non-alcoholic steatohepatitis. | Front Endocrinol (Lausanne) | 2023 | 37008925 | PubTator, text mining | PubMed |
| Shared miRNA landscapes of COVID-19 and neurodegeneration confirm neuroinflammation as an important overlapping feature. | Front Mol Neurosci | 2023 | 37008787 | PubTator, text mining | PubMed |
| TRABID overexpression enables synthetic lethality to PARP inhibitor via prolonging 53BP1 retention at double-strand breaks. | Nat Commun | 2023 | 37002234 | PubTator, text mining | PubMed |
| Diverse heterochromatin states restricting cell identity and reprogramming. | Trends Biochem Sci | 2023 | 36990958 | PubTator, text mining | PubMed |
| Chemical Inhibitors Targeting the Histone Lysine Demethylase Families with Potential for Drug Discovery. | Epigenomes | 2023 | 36975603 | PubTator, text mining | PubMed |
| E2F1-mediated KDM4A-AS1 up-regulation promotes EMT of hepatocellular carcinoma cells by recruiting ILF3 to stabilize AURKA mRNA. | Cancer Gene Ther | 2023 | 36973424 | PubTator, text mining | PubMed |
| Compound Danshen Dripping Pill inhibits hypercholesterolemia/atherosclerosis-induced heart failure in ApoE and LDLR dual deficient mice via multiple mechanisms. | Acta Pharm Sin B | 2023 | 36970211 | PubTator, text mining | PubMed |
| Multicenter Phase II Trial of the PARP Inhibitor Olaparib in Recurrent IDH1- and IDH2-mutant Glioma. | Cancer Res Commun | 2023 | 36968138 | PubTator, text mining | PubMed |
| Long noncoding RNAs with peptide-encoding potential identified in esophageal squamous cell carcinoma: KDM4A-AS1-encoded peptide weakens cancer cell viability and migratory capacity. | Mol Oncol | 2023 | 36965032 | PubTator, text mining | PubMed |
| Saturated fatty acids dampen the immunogenicity of cancer by suppressing STING. | Cell Rep | 2023 | 36952341 | PubTator, text mining | PubMed |
| Epigenetic control of mesenchymal stem cells orchestrates bone regeneration. | Front Endocrinol (Lausanne) | 2023 | 36950693 | PubTator, text mining | PubMed |
| Chemical tools targeting readers of lysine methylation. | Curr Opin Chem Biol | 2023 | 36948085 | PubTator, text mining | PubMed |
| Effects of overexpression of histone H3K9me3 demethylase on development of porcine cloned embryos. | Yi Chuan | 2023 | 36927639 | PubTator, text mining | PubMed |
| Exploring the common pathogenesis of Alzheimer's disease and type 2 diabetes mellitus via microarray data analysis. | Front Aging Neurosci | 2023 | 36923118 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9682/papers?page=12